Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,634,845
+$369,457 QoQ
Shares Held
2,757
+6.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Jun 30, 2022CallValue
$471,280
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CSS LLC/IL holds $5,129,429 across 8 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (31.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
2,757 | $1,634,845 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
6,950 | $915,593 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
27,070 | $815,348 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
37,616 | $780,908 | |
| 5 | ZTS |
Zoetis Inc.
|
6,220 | $735,266 | |
| 6 | VTRS |
Viatris Inc
|
8,520 | $115,105 | |
| 7 | YCBD |
cbdMD, Inc.
|
137,621 | $102,114 | |
| 8 | EVO |
Evotec SE
|
12,100 | $30,250 |
All Filings in UTHR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,634,845 | 2,757 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,265,388 | 2,597 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,319,253 | 3,147 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,050,838 | 3,657 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,225,989 | 3,977 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $821,058 | 2,327 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $733,542 | 2,047 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $556,506 | 1,747 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $516,870 | 2,250 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $560,719 | 2,550 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $553,381 | 2,450 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $618,100 | 2,800 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $559,900 | 2,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $500,562 | 1,800 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $397,822 | 1,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $471,280 | 2,000 | Call | Sole | 2022-08-15 | |
| 2022-06-30 | $541,972 | 2,300 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $358,820 | 2,000 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||